Botulinum toxin a for the treatment of a child with SUNCT syndrome

16Citations
Citations of this article
34Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) syndrome is an unusual cause of headache, mainly described in older adults, and is rare in children. Pain attacks may be severe, frequent, and prolonged. The therapeutic benefits of many drugs are disappointing. Patient and Methods: A 12-year-old boy suffered severe headache and toothache for 20 days. As treatment with nonsteroidal anti-inflammatory drugs, anticonvulsants, and steroids proved ineffective, he was treated with ipsilateral multisite subcutaneous injections of botulinum toxin A 70U around the orbit, the temporal area, and the upper gum. Results: The pain had reduced in frequency and severity by the fourth day after treatment and had completely disappeared after 7 days. There were no side effects or recurrence during a subsequent 17-month follow-up period. Conclusion: Botulinum toxin A can be used to treat the first episode of SUNCT in children over the age of 12 years.

Cite

CITATION STYLE

APA

Zhang, Y., Zhang, H., Lian, Y. J., Ma, Y. Q., Xie, N. C., Cheng, X., & Zhang, L. (2016). Botulinum toxin a for the treatment of a child with SUNCT syndrome. Pain Research and Management, 2016. https://doi.org/10.1155/2016/8016065

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free